These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 26215888)
1. Evaluating cost and resource use associated with pulse oximetry screening for critical congenital heart disease: Empiric estimates and sources of variation. Reeder MR; Kim J; Nance A; Krikov S; Feldkamp ML; Randall H; Botto LD Birth Defects Res A Clin Mol Teratol; 2015 Nov; 103(11):962-71. PubMed ID: 26215888 [TBL] [Abstract][Full Text] [Related]
2. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease. Peterson C; Grosse SD; Glidewell J; Garg LF; Van Naarden Braun K; Knapp MM; Beres LM; Hinton CF; Olney RS; Cassell CH Public Health Rep; 2014; 129(1):86-93. PubMed ID: 24381364 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge. Narayen IC; Te Pas AB; Blom NA; van den Akker-van Marle ME Eur J Pediatr; 2019 Jan; 178(1):97-103. PubMed ID: 30334077 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890 [TBL] [Abstract][Full Text] [Related]
5. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744 [TBL] [Abstract][Full Text] [Related]
6. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Roberts TE; Barton PM; Auguste PE; Middleton LJ; Furmston AT; Ewer AK Arch Dis Child; 2012 Mar; 97(3):221-6. PubMed ID: 22247242 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China. Tobe RG; Martin GR; Li F; Moriichi A; Wu B; Mori R Medicine (Baltimore); 2017 Nov; 96(46):e8683. PubMed ID: 29145300 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Knowles R; Griebsch I; Dezateux C; Brown J; Bull C; Wren C Health Technol Assess; 2005 Nov; 9(44):1-152, iii-iv. PubMed ID: 16297355 [TBL] [Abstract][Full Text] [Related]
9. Screening for critical congenital heart disease: advancing detection in the newborn. Bradshaw EA; Martin GR Curr Opin Pediatr; 2012 Oct; 24(5):603-8. PubMed ID: 22935755 [TBL] [Abstract][Full Text] [Related]
10. Neonatal pulse oximetry screening improves detecting of critical congenital heart disease. Ma XJ; Huang GY Chin Med J (Engl); 2013 Jul; 126(14):2736-40. PubMed ID: 23876906 [TBL] [Abstract][Full Text] [Related]
12. Critical congenital heart disease screening practices among licensed midwives in washington state. Evers PD; Vernon MM; Schultz AH J Midwifery Womens Health; 2015; 60(2):206-10. PubMed ID: 25782853 [TBL] [Abstract][Full Text] [Related]
13. Should postnatal oximetry screening be implemented nationwide in China? A cost-effectiveness analysis in three regions with different socioeconomic status. Tobe RG; Martin GR; Li F; Mori R Int J Cardiol; 2016 Feb; 204():45-7. PubMed ID: 26655534 [No Abstract] [Full Text] [Related]
15. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ; Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259 [TBL] [Abstract][Full Text] [Related]
16. Pulse oximetry screening for congenital heart defects. Ewer AK; Granelli AD; Manzoni P; Sánchez Luna M; Martin GR Lancet; 2013 Sep; 382(9895):856-7. PubMed ID: 24012266 [No Abstract] [Full Text] [Related]
17. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery. Johnson LC; Lieberman E; O'Leary E; Geggel RL Pediatrics; 2014 Nov; 134(5):916-22. PubMed ID: 25287457 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of pulse-oximetry in addition to routine neonatal examination in detection of congenital heart disease in asymptomatic newborns. Oakley JL; Soni NB; Wilson D; Sen S J Matern Fetal Neonatal Med; 2015; 28(14):1736-9. PubMed ID: 25241768 [TBL] [Abstract][Full Text] [Related]
19. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492 [TBL] [Abstract][Full Text] [Related]
20. Important considerations for the newborn: access to postdischarge newborn care, pulse oximetry screening for congenital heart disease, and circumcision. Pattishall AE; Spector ND; McPeak KE Curr Opin Pediatr; 2014 Dec; 26(6):734-40. PubMed ID: 25259474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]